🚀 Free trial period Request a free 14-day trial period now.

Start free trial period
GR

GRUNENTHAL

NV

0403.085.874

What does GRUNENTHAL do?

Grunenthal is a global pharmaceutical company specializing in pain management and innovative treatments. The company focuses on developing and commercializing products that enhance the quality of life for patients suffering from chronic pain. Grunenthal also emphasizes research and development in areas such as oncology and other therapeutic areas to address unmet medical needs.

Company number

0403.085.874

Location

Lenneke Marelaan 8 Zaventem 1932

Founding date

Founded in 12-10-1966

Juridical situation

Normale toestand

Juridical form

Naamloze vennootschap

Type of enterprise

Rechtspersoon
Profit
€ 1.64M
Increased by 3%
Equity
€ 7.52M
Increased by 17%
Turnover
€ 33.83M
Increased by 49%
Score

Very high risk

High risk

Average

Low risk

Very low risk

Financial ratios 2023 2022 2021
Equity
€ 7.52M
€ 6.42M
€ 5.30M
Turnover
€ 33.83M
€ 22.66M
€ 22.28M
Profit
€ 1.64M
€ 1.59M
€ 1.33M
EBITDA
€ 1.71M
€ 1.61M
€ 1.40M
Debt
€ 6.87M
€ 6.97M
€ 3.07M
Cash
Employees
24.30
22.30
21.30

Directors

All directors

Geert Bammens

Riemst

Carla Looye

BB Mijdrecht

Yann Omer

Woluwé-Saint-Pierre

Investments

Show all
No results found

Investors

No results found

Corporate structure

Full structure

Directors

Participations

Frequently asked questions

Sources

Ready to start?

Find out the financial situation of potential customers, suppliers or business partners by consulting official information and key figures.

App screenshot